Request for Covid-19 Impact Assessment of this Report
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Active Pharmaceutical Ingredients/API for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India
Global Active Pharmaceutical Ingredients/API market competition by top manufacturers/players, with Active Pharmaceutical Ingredients/API sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical Industries
Eli Lilly and Company
GlaxoSmithKline
Merck
AbbVie
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Innovative
Generic
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Active Pharmaceutical Ingredients/API for each application, including
Diabetes
Oncology
CNS
CVD
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Active Pharmaceutical Ingredients/API Sales Market Report 2017
1 Active Pharmaceutical Ingredients/API Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients/API
1.2 Classification of Active Pharmaceutical Ingredients/API by Product Category
1.2.1 Global Active Pharmaceutical Ingredients/API Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Active Pharmaceutical Ingredients/API Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Innovative
1.2.4 Generic
1.3 Global Active Pharmaceutical Ingredients/API Market by Application/End Users
1.3.1 Global Active Pharmaceutical Ingredients/API Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Diabetes
1.3.3 Oncology
1.3.4 CNS
1.3.5 CVD
1.4 Global Active Pharmaceutical Ingredients/API Market by Region
1.4.1 Global Active Pharmaceutical Ingredients/API Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Active Pharmaceutical Ingredients/API Status and Prospect (2012-2022)
1.4.3 China Active Pharmaceutical Ingredients/API Status and Prospect (2012-2022)
1.4.4 Europe Active Pharmaceutical Ingredients/API Status and Prospect (2012-2022)
1.4.5 Japan Active Pharmaceutical Ingredients/API Status and Prospect (2012-2022)
1.4.6 Southeast Asia Active Pharmaceutical Ingredients/API Status and Prospect (2012-2022)
1.4.7 India Active Pharmaceutical Ingredients/API Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Active Pharmaceutical Ingredients/API (2012-2022)
1.5.1 Global Active Pharmaceutical Ingredients/API Sales and Growth Rate (2012-2022)
1.5.2 Global Active Pharmaceutical Ingredients/API Revenue and Growth Rate (2012-2022)
2 Global Active Pharmaceutical Ingredients/API Competition by Players/Suppliers, Type and Application
2.1 Global Active Pharmaceutical Ingredients/API Market Competition by Players/Suppliers
2.1.1 Global Active Pharmaceutical Ingredients/API Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Active Pharmaceutical Ingredients/API Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Active Pharmaceutical Ingredients/API (Volume and Value) by Type
2.2.1 Global Active Pharmaceutical Ingredients/API Sales and Market Share by Type (2012-2017)
2.2.2 Global Active Pharmaceutical Ingredients/API Revenue and Market Share by Type (2012-2017)
2.3 Global Active Pharmaceutical Ingredients/API (Volume and Value) by Region
2.3.1 Global Active Pharmaceutical Ingredients/API Sales and Market Share by Region (2012-2017)
2.3.2 Global Active Pharmaceutical Ingredients/API Revenue and Market Share by Region (2012-2017)
2.4 Global Active Pharmaceutical Ingredients/API (Volume) by Application
3 United States Active Pharmaceutical Ingredients/API (Volume, Value and Sales Price)
3.1 United States Active Pharmaceutical Ingredients/API Sales and Value (2012-2017)
3.1.1 United States Active Pharmaceutical Ingredients/API Sales and Growth Rate (2012-2017)
3.1.2 United States Active Pharmaceutical Ingredients/API Revenue and Growth Rate (2012-2017)
3.1.3 United States Active Pharmaceutical Ingredients/API Sales Price Trend (2012-2017)
3.2 United States Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Players
3.3 United States Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Type
3.4 United States Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Application
4 China Active Pharmaceutical Ingredients/API (Volume, Value and Sales Price)
4.1 China Active Pharmaceutical Ingredients/API Sales and Value (2012-2017)
4.1.1 China Active Pharmaceutical Ingredients/API Sales and Growth Rate (2012-2017)
4.1.2 China Active Pharmaceutical Ingredients/API Revenue and Growth Rate (2012-2017)
4.1.3 China Active Pharmaceutical Ingredients/API Sales Price Trend (2012-2017)
4.2 China Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Players
4.3 China Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Type
4.4 China Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Application
5 Europe Active Pharmaceutical Ingredients/API (Volume, Value and Sales Price)
5.1 Europe Active Pharmaceutical Ingredients/API Sales and Value (2012-2017)
5.1.1 Europe Active Pharmaceutical Ingredients/API Sales and Growth Rate (2012-2017)
5.1.2 Europe Active Pharmaceutical Ingredients/API Revenue and Growth Rate (2012-2017)
5.1.3 Europe Active Pharmaceutical Ingredients/API Sales Price Trend (2012-2017)
5.2 Europe Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Players
5.3 Europe Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Type
5.4 Europe Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Application
6 Japan Active Pharmaceutical Ingredients/API (Volume, Value and Sales Price)
6.1 Japan Active Pharmaceutical Ingredients/API Sales and Value (2012-2017)
6.1.1 Japan Active Pharmaceutical Ingredients/API Sales and Growth Rate (2012-2017)
6.1.2 Japan Active Pharmaceutical Ingredients/API Revenue and Growth Rate (2012-2017)
6.1.3 Japan Active Pharmaceutical Ingredients/API Sales Price Trend (2012-2017)
6.2 Japan Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Players
6.3 Japan Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Type
6.4 Japan Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Application
7 Southeast Asia Active Pharmaceutical Ingredients/API (Volume, Value and Sales Price)
7.1 Southeast Asia Active Pharmaceutical Ingredients/API Sales and Value (2012-2017)
7.1.1 Southeast Asia Active Pharmaceutical Ingredients/API Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Active Pharmaceutical Ingredients/API Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Active Pharmaceutical Ingredients/API Sales Price Trend (2012-2017)
7.2 Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Players
7.3 Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Type
7.4 Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Application
8 India Active Pharmaceutical Ingredients/API (Volume, Value and Sales Price)
8.1 India Active Pharmaceutical Ingredients/API Sales and Value (2012-2017)
8.1.1 India Active Pharmaceutical Ingredients/API Sales and Growth Rate (2012-2017)
8.1.2 India Active Pharmaceutical Ingredients/API Revenue and Growth Rate (2012-2017)
8.1.3 India Active Pharmaceutical Ingredients/API Sales Price Trend (2012-2017)
8.2 India Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Players
8.3 India Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Type
8.4 India Active Pharmaceutical Ingredients/API Sales Volume and Market Share by Application
9 Global Active Pharmaceutical Ingredients/API Players/Suppliers Profiles and Sales Data
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Novartis International
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis International Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Sanofi
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Boehringer Ingelheim
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Bristol-Myers Squibb
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Teva Pharmaceutical Industries
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Eli Lilly and Company
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 GlaxoSmithKline
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Merck
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Merck Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 AbbVie
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Active Pharmaceutical Ingredients/API Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 AbbVie Active Pharmaceutical Ingredients/API Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
10 Active Pharmaceutical Ingredients/API Maufacturing Cost Analysis
10.1 Active Pharmaceutical Ingredients/API Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients/API
10.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients/API
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Active Pharmaceutical Ingredients/API Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Active Pharmaceutical Ingredients/API Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Active Pharmaceutical Ingredients/API Market Forecast (2017-2022)
14.1 Global Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Active Pharmaceutical Ingredients/API Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Active Pharmaceutical Ingredients/API Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Active Pharmaceutical Ingredients/API Price and Trend Forecast (2017-2022)
14.2 Global Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Active Pharmaceutical Ingredients/API Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Active Pharmaceutical Ingredients/API Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Active Pharmaceutical Ingredients/API Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Active Pharmaceutical Ingredients/API Sales Forecast by Type (2017-2022)
14.3.2 Global Active Pharmaceutical Ingredients/API Revenue Forecast by Type (2017-2022)
14.3.3 Global Active Pharmaceutical Ingredients/API Price Forecast by Type (2017-2022)
14.4 Global Active Pharmaceutical Ingredients/API Sales Volume Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Figure Product Picture of Active Pharmaceutical Ingredients/API
Figure Global Active Pharmaceutical Ingredients/API Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type (Product Category) in 2016
Figure Innovative Product Picture
Figure Generic Product Picture
Figure Global Active Pharmaceutical Ingredients/API Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Active Pharmaceutical Ingredients/API by Application in 2016
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure CNS Examples
Table Key Downstream Customer in CNS
Figure CVD Examples
Table Key Downstream Customer in CVD
Figure Global Active Pharmaceutical Ingredients/API Market Size (Million USD) by Regions (2012-2022)
Figure United States Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Active Pharmaceutical Ingredients/API Sales Volume (K Units) (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Active Pharmaceutical Ingredients/API Sales Share by Players/Suppliers
Figure 2017 Active Pharmaceutical Ingredients/API Sales Share by Players/Suppliers
Figure Global Active Pharmaceutical Ingredients/API Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Active Pharmaceutical Ingredients/API Revenue Share by Players
Table 2017 Global Active Pharmaceutical Ingredients/API Revenue Share by Players
Table Global Active Pharmaceutical Ingredients/API Sales (K Units) and Market Share by Type (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients/API by Type (2012-2017)
Figure Global Active Pharmaceutical Ingredients/API Sales Growth Rate by Type (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients/API by Type (2012-2017)
Figure Global Active Pharmaceutical Ingredients/API Revenue Growth Rate by Type (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Sales Share by Region (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients/API by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredients/API Sales Growth Rate by Region in 2016
Table Global Active Pharmaceutical Ingredients/API Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients/API by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredients/API Revenue Growth Rate by Region in 2016
Table Global Active Pharmaceutical Ingredients/API Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients/API by Region (2012-2017)
Figure Global Active Pharmaceutical Ingredients/API Revenue Market Share by Region in 2016
Table Global Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Active Pharmaceutical Ingredients/API Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Active Pharmaceutical Ingredients/API by Application (2012-2017)
Figure Global Active Pharmaceutical Ingredients/API Sales Market Share by Application (2012-2017)
Figure United States Active Pharmaceutical Ingredients/API Sales (K Units) and Growth Rate (2012-2017)
Figure United States Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Active Pharmaceutical Ingredients/API Sales Price (USD/Unit) Trend (2012-2017)
Table United States Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Players (2012-2017)
Table United States Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players (2012-2017)
Figure United States Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players in 2016
Table United States Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type (2012-2017)
Figure United States Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type in 2016
Table United States Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Application (2012-2017)
Table United States Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application (2012-2017)
Figure United States Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application in 2016
Figure China Active Pharmaceutical Ingredients/API Sales (K Units) and Growth Rate (2012-2017)
Figure China Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Active Pharmaceutical Ingredients/API Sales Price (USD/Unit) Trend (2012-2017)
Table China Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Players (2012-2017)
Table China Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players (2012-2017)
Figure China Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players in 2016
Table China Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Type (2012-2017)
Table China Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type (2012-2017)
Figure China Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type in 2016
Table China Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Application (2012-2017)
Table China Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application (2012-2017)
Figure China Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application in 2016
Figure Europe Active Pharmaceutical Ingredients/API Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Active Pharmaceutical Ingredients/API Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Players (2012-2017)
Table Europe Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players (2012-2017)
Figure Europe Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players in 2016
Table Europe Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Type (2012-2017)
Table Europe Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type (2012-2017)
Figure Europe Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type in 2016
Table Europe Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Application (2012-2017)
Table Europe Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application (2012-2017)
Figure Europe Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application in 2016
Figure Japan Active Pharmaceutical Ingredients/API Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Active Pharmaceutical Ingredients/API Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Players (2012-2017)
Table Japan Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players (2012-2017)
Figure Japan Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players in 2016
Table Japan Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Type (2012-2017)
Table Japan Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type (2012-2017)
Figure Japan Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type in 2016
Table Japan Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Application (2012-2017)
Table Japan Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application (2012-2017)
Figure Japan Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application in 2016
Figure Southeast Asia Active Pharmaceutical Ingredients/API Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players in 2016
Table Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type in 2016
Table Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application in 2016
Figure India Active Pharmaceutical Ingredients/API Sales (K Units) and Growth Rate (2012-2017)
Figure India Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Active Pharmaceutical Ingredients/API Sales Price (USD/Unit) Trend (2012-2017)
Table India Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Players (2012-2017)
Table India Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players (2012-2017)
Figure India Active Pharmaceutical Ingredients/API Sales Volume Market Share by Players in 2016
Table India Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Type (2012-2017)
Table India Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type (2012-2017)
Figure India Active Pharmaceutical Ingredients/API Sales Volume Market Share by Type in 2016
Table India Active Pharmaceutical Ingredients/API Sales Volume (K Units) by Application (2012-2017)
Table India Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application (2012-2017)
Figure India Active Pharmaceutical Ingredients/API Sales Volume Market Share by Application in 2016
Table Pfizer Basic Information List
Table Pfizer Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Pfizer Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Novartis International Basic Information List
Table Novartis International Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Novartis International Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Sanofi Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Teva Pharmaceutical Industries Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Eli Lilly and Company Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure Merck Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure Merck Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Active Pharmaceutical Ingredients/API Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients/API Sales Growth Rate (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients/API Sales Global Market Share (2012-2017
Figure AbbVie Active Pharmaceutical Ingredients/API Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients/API
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients/API
Figure Active Pharmaceutical Ingredients/API Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients/API Major Players in 2016
Table Major Buyers of Active Pharmaceutical Ingredients/API
Table Distributors/Traders List
Figure Global Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Active Pharmaceutical Ingredients/API Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Sales Volume Market Share Forecast by Regions in 2022
Table Global Active Pharmaceutical Ingredients/API Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Revenue Market Share Forecast by Regions in 2022
Figure United States Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Active Pharmaceutical Ingredients/API Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Active Pharmaceutical Ingredients/API Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Active Pharmaceutical Ingredients/API Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Active Pharmaceutical Ingredients/API Sales (K Units) Forecast by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Active Pharmaceutical Ingredients/API Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Revenue Market Share Forecast by Type (2017-2022)
Table Global Active Pharmaceutical Ingredients/API Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Active Pharmaceutical Ingredients/API Sales (K Units) Forecast by Application (2017-2022)
Figure Global Active Pharmaceutical Ingredients/API Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...